ConductScience.org, home

Paper178275

In vivo synergy between 6 beta-amidinopenicillanic acid derivatives and other antibiotics.

Grunberg E and 3 others. Antimicrob Agents Chemother, 1976. Cited by 69 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. In vivo synergy between 6 beta-amidinopenicillanic acid derivatives and other antibiotics. Papers, record 178275. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/178275

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
In vivo synergy between 6 beta-amidinopenicillanic acid derivatives and other antibiotics.
PubMed
Journal
Antimicrob Agents Chemother
PubMed
Year
1976
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
69
iCite
Relative citation ratio, by iCite
3.63
iCite
Revised in PubMed
2021-05-26
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Grunberg EE
2Cleeland RR
3Beskid GG
4DeLorenzo WFW F

Source PubMed

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anti-Bacterial AgentsMajor topic
BacteriaMajor topic
Penicillanic AcidMajor topic
Animals
Bacterial Infections
Drug Synergism
Mice

Source PubMed

References9

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
14,590,478Mechanism of action and development of resistance to a new amidino penicillin.J Bacteriol1974https://conductscience.org/library/papers/4590478PubMed
24,758,061Trimethoprim-sulfamethoxazole. Summary and comments on the conference.J Infect Dis1973https://conductscience.org/library/papers/4758061PubMed
31,157,572Pharmacokinetic studies with mecillinam and pivmecillinam.Chemotherapy1975https://conductscience.org/library/papers/1157572PubMed
4168,179Inhibition of an early event in the cell division cycle of Escherichia coli by FL1060, an amidinopenicillanic acid.J Bacteriol1975https://conductscience.org/library/papers/168179PubMed
5170,856Mecillinam (FL 1060), a 6beta-amidinopenicillanic acid derivative: bactericidal action and synergy in vitro.Antimicrob Agents Chemother1975https://conductscience.org/library/papers/170856PubMed
64,348,402FL 1060: a new beta-lactam antibiotic with novel properties.J Clin Pathol1973https://conductscience.org/library/papers/4348402PubMed
74,358,124The two sites of penicillin action in Escherichia coli.J Infect Dis1973https://conductscience.org/library/papers/4358124PubMed
84,402,0066 -amidinopenicillanic acids--a new group of antibiotics.Nat New Biol1972https://conductscience.org/library/papers/4402006PubMed
94,574,155FL-1060: a new penicillin with a unique mode of action.Biochem Biophys Res Commun1973https://conductscience.org/library/papers/4574155PubMed

Cited by17

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 69 citations.

PMIDTitleJournalYearIn PapersSource
6,423,179Combinations of beta lactam antibiotics.Br Med J (Clin Res Ed)1984https://conductscience.org/library/papers/6423179PubMed
6,289,730Treatment of experimental Salmonella typhimurium infection with mecillinam and ampicillin.Antimicrob Agents Chemother1981https://conductscience.org/library/papers/6289730PubMed
6,284,652Mecillinam alone and in combination with ampicillin or moxalactam in experimental Escherichia coli meningitis.Infection1982https://conductscience.org/library/papers/6284652PubMed
6,280,596Induction of cell lysis in Escherichia coli: cooperative effect of nocardicin A and mecillinam.Antimicrob Agents Chemother1982https://conductscience.org/library/papers/6280596PubMed
6,277,795Inhibitory activity and bactericidal kinetics of mecillinam/ampicillin combinations against Enterobacteriaceae, Pseudomonas and Acinetobacter.Infection1981https://conductscience.org/library/papers/6277795PubMed
6,263,179Activity of mecillinam alone and in combination with other beta-lactam antibiotics.Antimicrob Agents Chemother1980https://conductscience.org/library/papers/6263179PubMed
6,252,835Carbenicillin plus cefazolin with or without mecillinam as an early treatment of bacteremia caused by gram-negative organisms: randomized double-blind study.Antimicrob Agents Chemother1980https://conductscience.org/library/papers/6252835PubMed
6,246,005Pivmecillinam in the treatment of therapy resistant urinary tract infections. A comparison with pivmecillinam, pivampicillin and their combination.Infection1980https://conductscience.org/library/papers/6246005PubMed
3,494,745Influence of growth medium and supplement on growth of Haemophilus influenzae and on antibacterial activity of several antibiotics.J Clin Microbiol1987https://conductscience.org/library/papers/3494745PubMed
3,377,469Influence of food on bioavailability of amdinocillin pivoxil.Antimicrob Agents Chemother1988https://conductscience.org/library/papers/3377469PubMed
3,069,197Haemophilus influenzae: antibiotic susceptibility.Clin Microbiol Rev1988https://conductscience.org/library/papers/3069197PubMed
1,267,442Synergy of mecillinam (FL1060) with penicillins and cephalosporins against Proteus and Klebsiella, with observations on combinations with other antibiotics and against other bacterial species.Antimicrob Agents Chemother1976https://conductscience.org/library/papers/1267442PubMed
984,795Synergy of mecillinam, a beta-amidinopenicillanic acid derivative, combined with beta-lactam antibiotics.Antimicrob Agents Chemother1976https://conductscience.org/library/papers/984795PubMed
228,591Mecillinam-ampicillin synergism in experimental Enterobacteriaceae meningitis.Antimicrob Agents Chemother1979https://conductscience.org/library/papers/228591PubMed
193,439Comparison of the effects of mecillinam and 6-aminopenicillanic acid on Proteus mirabilis, Escherichia coli, and Staphylococcus aureus.Antimicrob Agents Chemother1977https://conductscience.org/library/papers/193439PubMed
189,683Comparison of the binding properties of two 6 beta-amidinopenicillanic acid derivatives that differ in their physiological effects on Escherichia coli.Antimicrob Agents Chemother1977https://conductscience.org/library/papers/189683PubMed
43,113Phosphonopeptides as antibacterial agents: alaphosphin and related phosphonopeptides.Antimicrob Agents Chemother1979https://conductscience.org/library/papers/43113PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/178275

GET https://conductscience.org/api/papers/v1/178275/authors